Status:
COMPLETED
Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)
Lead Sponsor:
Walter Reed Army Medical Center
Collaborating Sponsors:
Sumitomo Pharma America, Inc.
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-64 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the efficacy of Eszopiclone in improving short and intermediate-term compliance with continuous positive airway pressure (CPAP) in patients newly diagnosed with ...
Detailed Description
CPAP is the treatment of choice for patients with OSA. However, patients are frequently intolerant of this therapy initially. After continued use, tolerance is achieved. However, this initial discomfo...
Eligibility Criteria
Inclusion
- Adult patients
- Newly diagnosed with OSA who are prescribed CPAP therapy
Exclusion
- Patients \< 18 years old
- Patients over 65 years
- Pregnant women
- Patients with chronic liver disease
- Patients who abuse alcohol
- Patients taking narcotics or using sedative-hypnotic agents such as Ambien, Klonopin or Benadryl
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT00612157
Start Date
January 1 2008
End Date
February 1 2009
Last Update
February 26 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States, 20307